Performing Stronger Despite Roadblocks

The sectors we operate in, got impacted by various macro, regulatory and policy developments,
along with changing market and competitor dynamics, over the last few years.

Stringent USFDA inspections

Pricing pressures in the pharma sector

Real Estate Regulation and Development Act (RERA)


Goods and Services Tax (GST)

NBFC liquidity tightening

Most of these changes are expected to be beneficial in the long run. However, the pace of change
adversely impacted the performance of the financial services and pharma sectors over the last few years.